CareDx®

A new article in @CardioBusiness, featuring insights from @JeffTeuteberg and @JKobulnik , explores how our HeartCare platform—combining AlloMap® and AlloSure® Heart—is changing the post-transplant care path for #hearttransplant recipients.

Wrapping up a great few days at #ASTSWinter! Our interactive
symposium with Dr. Matthew Cooper and Dr. Zoe Stewart Lewis
featured real-world AlloSure® cases, discussions on incorporating
AlloSure® Plus into clinical decision-making, and new data from the
KOAR study. @ASTSChimera

At #ASH25, interim data from ACROBAT (prospective, multicenter) evaluated AlloHeme—NGS‑based blood surveillance post‑HCT for AML/MDS.
Serial monitoring with a multi‑analyte algorithm shows potential to enable timely intervention & more personalized care.
DM for the poster.

Exciting news! Dr. Nir Uriel is presenting new data from the SHORE registry in an oral presentation at #ISHLT2025 showing dual-positive HeartCare results are prognostic of worse outcomes, even when the biopsy is normal. ​

​Learn more: abstractsonline.com/pp8/#!/20756/p…​

​#HeartTransplant

We're thrilled to share the latest HeartCare data from SHORE at #ISHLT2025 investigating the association of redundant biopsies with outcomes. Spoiler alert – there was none! ​

​Dr. Jeff Teuteberg will be sharing more during an oral presentation: ​

abstractsonline.com/pp8/#!/20756/p…